199296-22-5 Usage
Uses
Used in Pharmaceutical Industry:
1(2H)-Pyrazineaceticacid,3-amino-6-methyl-2-oxo-(9CI) is used as an intermediate in the synthesis of pharmaceuticals for its role in creating pyrazine-containing drugs. Its unique structure contributes to the development of novel medications with potential therapeutic benefits.
Used in Agrochemical Industry:
In the agrochemical industry, 1(2H)-Pyrazineaceticacid,3-amino-6-methyl-2-oxo-(9CI) is used as a building block for the production of agrochemicals, specifically those containing pyrazine. Its incorporation into these compounds can lead to the development of new pesticides or other agricultural products with enhanced efficacy.
Used in Research and Development:
1(2H)-Pyrazineaceticacid,3-amino-6-methyl-2-oxo-(9CI) is utilized in research and development as a key compound for exploring new chemical entities with potential biological activities. Its unique structure and properties make it a promising candidate for creating innovative molecules with applications in various fields, including medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 199296-22-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,2,9 and 6 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 199296-22:
(8*1)+(7*9)+(6*9)+(5*2)+(4*9)+(3*6)+(2*2)+(1*2)=195
195 % 10 = 5
So 199296-22-5 is a valid CAS Registry Number.
199296-22-5Relevant academic research and scientific papers
Non-peptide αvβ3 antagonists. Part 6: Design and synthesis of αvβ3 antagonists containing a pyridone or pyrazinone central scaffold
Breslin, Michael J.,Duggan, Mark E.,Halczenko, Wasyl,Fernandez-Metzler, Carmen,Hunt, Cecilia A.,Leu, Chih-Tai,Merkle, Kara M.,Naylor-Olsen, Adel M.,Prueksaritanont, Thomayant,Stump, Gary,Wallace, Audrey,Rodan, Sevgi B.,Hutchinson, John H.
, p. 1809 - 1812 (2007/10/03)
Two novel series of small-molecule RGD mimetics containing either a substituted pyridone or pyrazinone central constraint were prepared. Modification of the β-alanine 3-substituent produced compounds that are potent and selective αvβ3 antagonists and exhibit a range of physicochemical properties.
